Literature DB >> 11835215

The effect of disorder on the chemical reactivity of an organic solid, tetraglycine methyl ester: change of the reaction mechanism.

Evgenyi Shalaev1, Marina Shalaeva, George Zografi.   

Abstract

Many drugs undergo chemical changes in the solid state, and understanding chemical reactivity of organic crystals is a critical factor in the drug development process. In this report, the impact of milling on the thermal chemical reactivity of an organic solid, tetraglycine methyl ester, was studied using DSC, isothermal calorimetry, chemical analysis (HPLC and insoluble residue determination), and powder X-ray diffraction. Significant changes in both X-ray diffraction patterns and DSC curves were detected after very brief milling (5 s). The changes were interpreted as the formation of a disordered phase. The disordered phase was tentatively identified as a crystal mesophase that combines properties of both crystalline (i.e., long-range order) and amorphous (i.e., glass transition) states. In the disordered material, the reaction mechanism changed from the methyl transfer reaction, which was observed in the intact crystal, to a polycondensation reaction when the reaction was performed at 165 degrees C. Such changes in the reaction mechanism occurred in materials milled for > 30 s. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:584-593, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835215     DOI: 10.1002/jps.10066

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs.

Authors:  Norbert Rasenack; Bernd W Müller
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

2.  Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.

Authors:  Niraj S Trasi; Stephen R Byrn
Journal:  AAPS PharmSciTech       Date:  2012-05-15       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.